Pfizer Inc. (PFE)
NYSE: PFE · Real-Time Price · USD
25.01
+0.10 (0.40%)
At close: Jul 31, 2026, 4:00 PM EDT
25.04
+0.03 (0.12%)
After-hours: Jul 31, 2026, 7:59 PM EDT
Pfizer Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 142,543 | 141,581 | 150,346 | 162,548 | 287,764 | 331,861 | |
Market Cap Growth | 3.18% | -5.83% | -7.51% | -43.51% | -13.29% | 61.95% |
Enterprise Value | 194,193 | 193,079 | 194,514 | 222,020 | 301,117 | 339,490 |
Last Close Price | 25.01 | 24.90 | 26.53 | 28.79 | 51.24 | 59.05 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 19.08 | 18.31 | 18.82 | 77.81 | 9.37 | 15.34 |
Forward PE | 8.76 | 8.54 | 9.91 | 19.25 | 10.82 | 10.64 |
PEG Ratio | - | 29.47 | 1.27 | 1.32 | 5.15 | 1.00 |
PS Ratio | 2.25 | 2.26 | 2.36 | 2.73 | 2.84 | 4.08 |
PB Ratio | 1.58 | 1.64 | 1.70 | 1.83 | 3.01 | 4.30 |
P/TBV Ratio | - | - | - | - | 320.70 | 118.39 |
P/FCF Ratio | 15.03 | 15.60 | 15.29 | 33.91 | 11.05 | 11.11 |
P/OCF Ratio | 11.89 | 12.10 | 11.80 | 18.68 | 9.83 | 10.19 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 3.07 | 3.09 | 3.06 | 3.73 | 2.98 | 4.18 |
EV/EBITDA Ratio | 13.40 | 13.68 | 12.94 | 30.22 | 7.57 | 11.51 |
EV/EBIT Ratio | 24.57 | 25.68 | 24.24 | 210.05 | 8.67 | 13.96 |
EV/FCF Ratio | 20.48 | 21.28 | 19.78 | 46.32 | 11.57 | 11.37 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.71 | 0.75 | 0.73 | 0.81 | 0.37 | 0.50 |
Debt / EBITDA Ratio | 4.45 | 4.59 | 4.28 | 9.79 | 0.90 | 1.30 |
Debt / FCF Ratio | 6.80 | 7.14 | 6.54 | 15.00 | 1.38 | 1.29 |
Net Debt / Equity Ratio | 0.57 | 0.59 | 0.50 | 0.67 | 0.14 | 0.10 |
Net Debt / EBITDA Ratio | 3.55 | 3.63 | 2.92 | 8.06 | 0.33 | 0.25 |
Net Debt / FCF Ratio | 5.42 | 5.64 | 4.46 | 12.35 | 0.50 | 0.25 |
Asset Turnover | 0.30 | 0.30 | 0.29 | 0.28 | 0.53 | 0.48 |
Inventory Turnover | 1.57 | 1.49 | 1.70 | 2.60 | 3.81 | 3.61 |
Quick Ratio | 0.75 | 0.69 | 0.74 | 0.51 | 0.80 | 1.00 |
Current Ratio | 1.25 | 1.16 | 1.17 | 0.91 | 1.22 | 1.40 |
Return on Equity (ROE) | 8.49% | 8.89% | 9.06% | 2.35% | 36.22% | 31.87% |
Return on Assets (ROA) | 3.62% | 3.69% | 3.66% | 1.02% | 16.58% | 13.38% |
Return on Invested Capital (ROIC) | 5.38% | 5.76% | 5.73% | 1.69% | 32.40% | 25.53% |
Return on Capital Employed (ROCE) | 4.59% | 4.40% | 4.60% | 0.63% | 23.63% | 18.20% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 5.26% | 5.46% | 5.31% | 1.29% | 10.68% | 6.52% |
FCF Yield | 6.65% | 6.41% | 6.54% | 2.95% | 9.05% | 9.00% |
Dividend Yield | 6.88% | 6.90% | 6.33% | 5.69% | 3.13% | 2.64% |
Payout Ratio | 131.03% | 125.74% | 118.44% | 436.39% | 28.63% | 39.72% |
Buyback Yield / Dilution | -0.26% | -0.23% | 0.16% | 0.42% | -0.44% | -1.35% |
Total Shareholder Return | 6.61% | 6.68% | 6.49% | 6.11% | 2.69% | 1.29% |